[Clinical trial of etophamide in the treatment of chronic intestinal amebiasis].

Abstract

The author present the results obtained in the treatment of 100 patients suffering chronic intestinal amebiasis, employing a new drug--Etophamide, in a dose of 1,0 g per day, for three consecutive days. The tolerance of a new antiamebic drug was excellent in all patients, and the parasitological cure rate obtained was 92%. The author concluded that the new derivate amebicide used in this research is very effective for treatment of intestinal amebiasis infections.

• Authors: D Huggins
• Journal: G.E.N (G E N) 1980 Jan-Mar Vol. 34 Issue 1 Pg. 51-4 ISSN: 0016-3503 [Print] Venezuela
• Vernacular Title: Ensaio clínico com etofamida no tratamento da amebíase intestinal crônica.
• PMID: 6778767 (Publication Type: English Abstract, Journal Article)

Chemical References

• Acetamides
• Amebicides
• Ethers
• etofamide

Topics

• Acetamides (administration & dosage, therapeutic use)
• Adolescent
• Adult
• Aged
• Amebicides (therapeutic use)
• Child
• Chronic Disease
• Drug Evaluation
• Dysentery, Amebic (drug therapy)
• Ethers (administration & dosage, therapeutic use)
• Female
• Humans
• Male
• Middle Aged